Literature DB >> 11823510

Class II transactivator is required for maximal expression of HLA-DOB in B cells.

Uma M Nagarajan1, Jonathan Lochamy, Xinjian Chen, Guy W Beresford, Roger Nilsen, Peter E Jensen, Jeremy M Boss.   

Abstract

HLA-DO, encoded by the HLA-DOA and HLA-DOB genes, has been shown to function as a modulator of Ag presentation. DNA microarray comparisons between B cells wild-type and mutant for the master regulator of MHC class II transcription, class II transactivator (CIITA), identified HLA-DOA and HLA-DOB as being up-regulated by CIITA. Although HLA-DOA had been shown previously to be regulated by CIITA, HLA-DOB expression was suggested to be independent of CIITA. A series of assays including quantitative RT-PCR, promoter-reporter assays, chromatin immunoprecipitations, and intracellular staining were performed to corroborate the DNA microarray analysis. The combined data demonstrate that HLA-DOB levels are increased by CIITA, and that this difference has an impact on the overall level of HLA-DO expression. Additionally, unlike the classical MHC class II genes, HLA-DOB expression was present in the absence of CIITA, indicating that additional factors mediate HLA-DOB expression in B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823510     DOI: 10.4049/jimmunol.168.4.1780

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.

Authors:  Parimal Majumder; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

3.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

Review 4.  MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

5.  Persistence of MHC DR nonexpression on swine cells by introduction of a mutated MHC class II transactivator gene: a comparison with the effect induced by antisense RNA.

Authors:  Qishui Ou; Lin Lin; Lidong Huang; Fuxiang Chen; Kegui Wu; Peihua Lu; Jingwu Zhang; Kuang-Yen Chou
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

6.  Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.

Authors:  Christina Lönnroth; Marianne Andersson; Annette Arvidsson; Svante Nordgren; Hans Brevinge; Kristina Lagerstedt; Kent Lundholm
Journal:  Cancer Immun       Date:  2008-02-29

7.  CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments.

Authors:  W M Zinzow-Kramer; A B Long; B A Youngblood; K M Rosenthal; R Butler; A-U-R Mohammed; I Skountzou; R Ahmed; B D Evavold; J M Boss
Journal:  Genes Immun       Date:  2012-01-05       Impact factor: 2.676

8.  Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke.

Authors:  Nancy L Monson; Sterling B Ortega; Sara J Ireland; Anouk Jm Meeuwissen; Ding Chen; Erik J Plautz; Erin Shubel; Xiangmei Kong; Min K Li; Laura H Freriks; Ann M Stowe
Journal:  J Neuroinflammation       Date:  2014-01-31       Impact factor: 8.322

9.  Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.

Authors:  Chong Li; Lei Jin; Yun Bai; Qimin Chen; Lijun Fu; Minjun Yang; Huasheng Xiao; Guoping Zhao; Shengyue Wang
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  An Unbiased Machine Learning Exploration Reveals Gene Sets Predictive of Allograft Tolerance After Kidney Transplantation.

Authors:  Qiang Fu; Divyansh Agarwal; Kevin Deng; Rudy Matheson; Hongji Yang; Liang Wei; Qing Ran; Shaoping Deng; James F Markmann
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.